Cytek Biosciences Inc
Company Profile
Business description
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
Contact
47215 Lakeview Boulevard
FremontCA94538
USAT: +1 877 922-9835
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2024
Employees
645
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,416.60 | 57.70 | -0.68% |
CAC 40 | 7,541.36 | 63.58 | 0.85% |
DAX 40 | 19,120.93 | 105.52 | 0.55% |
Dow JONES (US) | 42,352.75 | 341.16 | 0.81% |
FTSE 100 | 8,280.63 | 1.89 | -0.02% |
HKSE | 22,736.87 | 623.36 | 2.82% |
NASDAQ | 18,137.85 | 219.37 | 1.22% |
Nikkei 225 | 38,635.62 | 83.56 | 0.22% |
NZX 50 Index | 12,619.94 | 47.28 | 0.38% |
S&P 500 | 5,751.07 | 51.13 | 0.90% |
S&P/ASX 200 | 8,150.00 | 55.20 | -0.67% |
SSE Composite Index | 3,336.50 | 248.97 | 8.06% |